Home › Agent Hub › Agent Tools › Part D coverage by drug › Fesoterodine
Agent Tools
Fesoterodine is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 2,938 of 5,492 Medicare Part D and Medicare Advantage drug plans (53.5%) list Fesoterodine on their formulary, across 159 of 286 formularies. The most common placement is tier 4 (2,247 plans, 76.5% of those covering it). 9 of the covering plans require prior authorization (0.3%), 0 step therapy and 2,576 a quantity limit.
310 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $7, 114 of them $0; 2,628 charge coinsurance instead — median 28% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 2,913 of 5,496 plans covered it (53%); 2027: 2,938 of 5,492 (53.5%).
Of 4,367 plans offered in both years, 241 added it to the formulary and 197 dropped it.
Among plans covering it both years, 805 moved it to a higher tier and 15 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 114 |
| Tier 2 | 216 |
| Tier 3 | 361 |
| Tier 4 | 2,247 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 124 of 323 | 38.4% | 0% |
| Medicare Advantage with drugs (MA-PD) | 1,701 of 3,200 | 53.2% | 0.2% |
| Special needs plans (SNP) | 1,113 of 1,969 | 56.5% | 0.5% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 4 | 0 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 446 of 728 | Tier 4 | 0 |
| Aetna Medicare | 631 of 631 | Tier 4 | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 69 of 74 | Tier 3 | 0 |
| Wellpoint | 50 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 3 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 4 | 0 |
| Zing Health | 6 of 36 | Tier 4 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 25 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 4 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 67 of 114 | 58.8% |
| Alaska | 4 of 9 | 44.4% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 83 of 147 | 56.5% |
| Arkansas | 44 of 85 | 51.8% |
| California | 199 of 397 | 50.1% |
| Colorado | 55 of 106 | 51.9% |
| Connecticut | 30 of 54 | 55.6% |
| Delaware | 17 of 43 | 39.5% |
| District of Columbia | 3 of 12 | 25% |
| Florida | 315 of 545 | 57.8% |
| Georgia | 79 of 149 | 53% |
| Guam | 0 of 1 | 0% |
| Hawaii | 21 of 50 | 42% |
| Idaho | 14 of 45 | 31.1% |
| Illinois | 64 of 132 | 48.5% |
| Indiana | 87 of 138 | 63% |
| Iowa | 40 of 64 | 62.5% |
| Kansas | 51 of 84 | 60.7% |
| Kentucky | 79 of 121 | 65.3% |
| Louisiana | 68 of 125 | 54.4% |
| Maine | 31 of 52 | 59.6% |
| Maryland | 19 of 49 | 38.8% |
| Massachusetts | 31 of 89 | 34.8% |
| Michigan | 133 of 182 | 73.1% |
| Minnesota | 21 of 63 | 33.3% |
| Mississippi | 44 of 104 | 42.3% |
| Missouri | 106 of 170 | 62.4% |
| Montana | 17 of 27 | 63% |
| Nebraska | 27 of 51 | 52.9% |
| Nevada | 49 of 100 | 49% |
| New Hampshire | 12 of 25 | 48% |
| New Jersey | 47 of 73 | 64.4% |
| New Mexico | 21 of 68 | 30.9% |
| New York | 124 of 215 | 57.7% |
| North Carolina | 96 of 176 | 54.5% |
| North Dakota | 10 of 26 | 38.5% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 94 of 171 | 55% |
| Oklahoma | 48 of 81 | 59.3% |
| Oregon | 43 of 92 | 46.7% |
| Pennsylvania | 147 of 323 | 45.5% |
| Puerto Rico | 0 of 64 | 0% |
| Rhode Island | 8 of 29 | 27.6% |
| South Carolina | 56 of 89 | 62.9% |
| South Dakota | 14 of 30 | 46.7% |
| Tennessee | 98 of 156 | 62.8% |
| Texas | 225 of 407 | 55.3% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 30 of 53 | 56.6% |
| Vermont | 7 of 14 | 50% |
| Virginia | 82 of 144 | 56.9% |
| Washington | 49 of 114 | 43% |
| West Virginia | 42 of 69 | 60.9% |
| Wisconsin | 56 of 96 | 58.3% |
| Wyoming | 7 of 13 | 53.8% |
Medicare Part D paid for 283,878 30-day fills of Fesoterodine in 2024 for about 37,747 enrollees, at an average total cost of $62.21 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Fesoterodine and the rest of a client's list on every plan in their county.
Estimate Fesoterodine costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.